On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayJun 08, 2022 12:59 pm

NetworkNewsBreaks – Bit Digital Inc. (NASDAQ: BTBT) Reports May 2022 Production Update

Bit Digital Inc. (NASDAQ: BTBT), a Bitcoin mining company headquartered in New York, has released its Bitcoin production numbers and corporate updates for May 2022. Highlights of the report indicate that the company earned 53.4 bitcoins and 27.0 ETHs in May, with treasury holdings of BTC and ETH totaling 793.6 and 316.1 respectively; fair market value of each are approximately $25.2 million and $0.6 million, respectively. In addition, the company reports that as of May 31, 2022, it owned 33,376 Bitcoin miners and 731 Ethereum miners with an estimated maximum total hash rate of 2.17 EH/s and 0.3 TH/s, respectively. Regarding miner deployments during…

Continue Reading

WednesdayJun 08, 2022 12:18 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Grants DehydraTECH(TM) License to Ireland-Based AnodGen Bioceuticals

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the awarding of a five-year, non-exclusive DehydraTECH(TM) license from its wholly-owned subsidiary, Lexaria Pharmaceutical Corp., to AnodGen Bioceuticals of Ireland. According to the update, the awarded license is valid for the manufacturing and distribution of DehydraTECH-processed cannabinoid active pharmaceutical ingredient (“API”) powders within Europe including the U.K., Australia and New Zealand; including pharmaceutical and medical product applications for psychoactive cannabinoids and medical product applications for non-psychoactive cannabinoids. AnodGen, which has the right to manufacture and sell these API powders to third party companies for their own…

Continue Reading

WednesdayJun 08, 2022 12:00 pm

NetworkNewsBreaks – SRAX Inc.’s (NASDAQ: SRAX) Upcoming Event to Highlight Prominent Names and Companies in Decentralized Web Space

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced that the Sequire Decentralized Web Conference will take place on June 23, 2022. As blockchain, DAOs, NFTS and digital currencies take off around the world with far-reaching potential, SRAX is bringing together a list of influential companies making history in this sector for a full day of presentations. Nearly nine million active small-cap investors were invited to the event, which will feature over 15 decentralized web focused companies and keynotes highlighting prominent names in this space.…

Continue Reading

WednesdayJun 08, 2022 11:41 am

NetworkNewsBreaks – Home Bistro Inc. (HBIS) Engages Alab Group for Brand Strategy Expertise

Home Bistro (OTC: HBIS), a leading online meal delivery platform that offers celebrity chef-inspired, gourmet and lifestyle ready-made meals, today announced that it has retained public relations firm Alab Group, known for its work across hospitality, food and lifestyle initiatives, to assist in the development of new brand strategies. Under the collaboration, Alab will work with an initial focus on Home Bistro to oversee, develop and execute an overarching communication strategy with a secondary phase to support the Model Meals’ brand. “Our new relationship with Alab is extremely important to the company’s continued growth,” said Home Bistro’s Chief Marketing Officer…

Continue Reading

WednesdayJun 08, 2022 11:30 am

NetworkNewsBreaks – Houston Natural Resources Corp. (HNRC) Announces $10M Acquisition of Water Treatment Company

Houston Natural Resources (OTC: HNRC) has entered into an agreement to acquire additional wastewater treatment facilities; the strategic move aligns with the company’s focus on developing  a network of wastewater treatment facilities. According to the announcement, the acquisition, which should close this month, involves a water-well services and drilling company. The company has a recurring customer/service revenue of 68% with a projected recurring customer/service revenue of 80% looking forward. The seven-year-old company focuses in municipal, mining, industrial and agricultural water wells and pump systems with operations in the western region of the country; the company’s fleet includes both small and…

Continue Reading

TuesdayJun 07, 2022 1:03 pm

NetworkNewsBreaks – Eat Well Investment Group Inc.’s (CSE: EWG) (OTC: EWGFF) Products Gaining Increased Distribution Amid Growing Interest in Plant-Based Foods

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) is “a vertically integrated plant-based foods investment company that has been rapidly building its portfolio of production and distribution brands during the past year to market to growing consumer interest. Bloomberg Intelligence analysis reported expectations that the market will see explosive growth in coming years, forecasting plant-based foods will increase their representation in the global market to 7.7% by 2030 with an exponential increase in valuation to more than $162 billion,” a recent article reads. “Eat Well’s three major investments — ingredients processor Belle Pulses, food creator Sapientia, and baby food brand…

Continue Reading

TuesdayJun 07, 2022 12:52 pm

NetworkNewsBreaks – Why Odyssey Health Inc. (ODYY) Is ‘One to Watch’

Odyssey Health (OTC: ODYY) is a medical technology company focused on developing lifesaving products that offer technological and clinical advantages over current standards of care. Guided by a senior management team with significant experience relating to refining acquired technologies, building commercial systems, and forging strategic partnerships, the company boasts a diverse development portfolio spanning both pharmaceutical candidates and medical devices. “Odyssey has two pharmaceutical products in development: PRV-002 and PRV-001. PRV-002 is a novel compound for the treatment of concussion, which currently has no FDA-approved drug. In pre-clinical studies, PRV-002 has been shown to significantly improve both neuroscore and memory…

Continue Reading

TuesdayJun 07, 2022 11:26 am

NetworkNewsBreaks – Coinbase Global Inc. (NASDAQ: COIN) Announces Participation in Upcoming Morgan Stanley US Financials, Payments & CRE Conference

Coinbase Global Inc. (NASDAQ: COIN) will be presenting at the next Morgan Stanley US Financials, Payments & CRE Conference. The company announced that Brett Tejpaul, head of Coinbase Institutional, will be part of  a fireside chat at the Morgan Stanley conference. The presentation is slated for Monday, June 13, 2022, with the fireside chat scheduled to start at 3:15 p.m. ET. Those interested can watch the live presentation on the Coinbase investor relations website; a replay of the presentation will also be available. Started in 2012, Coinbase was established with the goal of building a more fair, accessible, efficient and…

Continue Reading

TuesdayJun 07, 2022 11:16 am

NetworkNewsBreaks – SPYR Technologies (SPYR) Announces FCC Approval, PTCRB Certification of GeoTraq’s Tracker Module

SPYR (OTCQB: SPYR), a technology company, today announced that its subsidiary GeoTraq’s Tracker Module (“GT-TM100”) is FCC approved and ready for the market. According to the update, the GT-TM100 has successfully completed certification testing required by the PCS Type Certification Review Board (“PTCRB”) and is in compliance with FCC Part 15 Subpart B, Class B (“sDoC”) performance specifications. The PTCRB program provides confidence that devices perform optimally on mobile wireless networks and conform with global standards. “The Tracker Module is a complete, ‘self-contained’ device that can easily be inserted into any device, asset or package to connect it to the…

Continue Reading

TuesdayJun 07, 2022 11:06 am

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Acquisition of Entheon Biomedical’s DMT Clinical Study

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, has entered an agreement to acquire the largest phase 1 DMT study conducted to date. The acquisition, conducted through Cybin IRL Limited, a wholly owned subsidiary of Cybin, is expected to accelerate Cybin’s CYB004 program timeline by an estimated nine months; CYB004 is Cybin’s proprietary deuterated DMT molecule designed for the potential treatment of anxiety disorders.. The phase 1 N,N-dimethyltryptamine (“DMT”) study is focused on evaluating pharmacokinetics/pharmacodynamics of DMT currently underway and is expected to significantly impact the clinical path forward. Renamed CYB004-E, the phase 1 EBRX-101…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217